← FDA Drug Approvals (Drugs@FDA)
ERTUGLIFLOZIN
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: AUROBINDO PHARMA LTD · Approved 2023-07-13
Drug application
- FDA Application #
ANDA216947- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- ERTUGLIFLOZIN
- Generic name
- Ertugliflozin
- Active ingredients
- ERTUGLIFLOZIN
- Dosage form
- TABLET
- Route
- ORAL
- Marketing status
- Discontinued
- Sponsor
- AUROBINDO PHARMA LTD
- First approval
- 2023-07-13
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown